MedPath

AMORE FILIPPO

🇮🇹Italy
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

MP-3 Biofeedback Training and Central Vision Loss

Not Applicable
Completed
Conditions
Age-Related Macular Degeneration
First Posted Date
2023-03-16
Last Posted Date
2023-03-16
Lead Sponsor
Amore Filippo
Target Recruit Count
24
Registration Number
NCT05772780
Locations
🇮🇹

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

Telerehabilitation for Visually Impaired

Completed
Conditions
Visual Impairment
First Posted Date
2023-03-16
Last Posted Date
2023-03-16
Lead Sponsor
Amore Filippo
Target Recruit Count
50
Registration Number
NCT05772793
Locations
🇮🇹

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

Quality of Life in Italian Visually Impaired Patients

Recruiting
Conditions
Visual Impairment
First Posted Date
2023-03-02
Last Posted Date
2023-03-02
Lead Sponsor
Amore Filippo
Target Recruit Count
500
Registration Number
NCT05752214
Locations
🇮🇹

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.